Jeremy Cuthbertson, MD
Retina Specialist · El Paso, TXNPI 1902809247
Payments from drug & device makers
What this record shows
17 manufacturers reported payments, led by US Retina LLC at 51.2% of the total. Reporting peaked in 2022 at $3,416 and has fallen 79.7% since, to $695 in 2025.
Across 66 payments — averaging $177.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- US Retina LLC$6K
- Genentech USA, Inc.$956
- Regeneron Healthcare Solutions, Inc.$838
- Regeneron$741
- Alcon$671
- Alimera Sciences, Inc.$569
- plus $2K from 11 others
What the payments were for
- Food & beverage$5,70349%
- Ownership interest$5,99251%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| US Retina LLC | 6 | $5,992 |
| Genentech USA, Inc. | 13 | $956 |
| Regeneron Healthcare Solutions, Inc. | 9 | $838 |
| Regeneron | 6 | $741 |
| Alcon | 6 | $671 |
| Alimera Sciences, Inc. | 5 | $569 |
| Astellas Pharma US Inc | 4 | $407 |
| AbbVie | 4 | $386 |
| Eyepoint US, Inc. | 3 | $242 |
| Amgen | 2 | $196 |
| Biogen | 2 | $165 |
| Apellis Pharmaceuticals, Inc. | 1 | $123 |
| Carl Zeiss Meditec USA, Inc. | 1 | $108 |
| Novartis | 1 | $100 |
| Harrow Eye, LLC | 1 | $85 |
| Optos, Inc. | 1 | $78 |
| Iridex Corporation | 1 | $38 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,695 in reported general payments places this provider in the 80th percentile of 108 retina specialist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 91 | $2,787 |
| MoxifloxacinMoxifloxacin Hcl | 89 | $2,173 |
| Cyclopentolate Hcl | 36 | $455 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in El Paso
- Dinesh BahlEl Paso$13K
- David MetrikinEl Paso$11K
- Daniel KasugaEl Paso$9K
- Gregory TrubowitschEl Paso$8K
- Richard HwangEl Paso$3K
- Erica Alvarez GonzalezEl Paso$2K
- Courtney CrawfordBurleson$342K
- Jeremiah BrownSchertz$339K
- Victor GonzalezMcAllen$335K
- Judy KimDallas$256K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.